Sign in
4

Changes in Ownership

Perspective Therapeutics, Inc. Filed Acc 0001437749-18-020969

Controller/Prin Fin&Acct Offic bought 2,452 shares at $0.41 ($1,005)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Austin Mark John Controller/Prin Fin&Acct Offic 2018-11-13 Purchase +2,452 $0.41 $1,005 11,717 D: show line 1 in the form
Open-market purchases · 2,452 sh · avg $0.41 · $1,005
Loading xslF345X03/rdgdoc.xml…